Back to 
NATIONAL BANK OF CANADA /FI/
NATIONAL BANK OF CANADA /FI/
KYMR
Showing 0 of 3 quarters
Position history for NATIONAL BANK OF CANADA /FI/'s holdings in KYMERA THERAPEUTICS INC
No. National Bank of Canada exited its KYMR (Kymera Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 600 shares. National Bank of Canada first reported KYMR in Q2 2022 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.